Galileo and Fujikura in distribution agreement:
This article was originally published in Clinica
Galileo Electro-Optics is to distribute Fujikura's high pixel count optical fibre for endoscopic medical devices in the US and Puerto Rico. The product will be marketed under the name Ultra-Vue and will be available in 10,000, 15,000 and 30,000 pixel count formats. Fujikura, which is headquartered in Tokyo, Japan, manufactures fibre-optic and electronic products for a broad range of applications. US company Galileo manufactures and markets fibre-optics and electro-optic components and systems for transmitting, sensing or intensifying light or images.
You may also be interested in...
Formal dispute resolution was key element in four-month turnaround from rejection by US FDA to approval for golodirsen, the second Sarepta DMD drug to clear the agency after appearing to have minimal prospects.
Correvio’s attempt to move vernakalant from 'clinical hold' to 'FDA approved' was a huge long shot. But the advisory committee vote – and looming FDA rejection – are another indication that real-world data is not a panacea.